Immune Checkpoint Inhibitors Plus an Anti-VEGF Antibody as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis

Overview of attention for article published in Frontiers in Pharmacology, June 2022

Altmetric Badge

Mentioned by

So far, Dimensions has found 12 publications that cite this research output.

Article in Expert Review of Pharmacoeconomics & Outcomes Research (July 2024)

Article in Health Economics Review (July 2024)

Book chapter (July 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.